BIOMARIN PHARMACEUTICAL INC
Public company- Headquarters
- NOVATO, California
- Ticker
- BMRN
- CIK
- 0001048477
WARN notices since 2024
8
First: May 14, 2024
Workers affected since 2024
396
Across 8 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Sep 24, 2026
WARN noticeWARN notice: Novato, CA
Workers affected over time
Cumulative workers in WARN notices since 2024
| Notice date | Workers affected | Cumulative |
|---|---|---|
| May 14, 2024 | 57 | 57 |
| May 14, 2024 | 1 | 58 |
| May 14, 2024 | 71 | 129 |
| May 14, 2024 | 3 | 132 |
| Aug 28, 2024 | 1 | 133 |
| Aug 28, 2024 | 94 | 227 |
| Aug 28, 2024 | 52 | 279 |
| Sep 24, 2026 | 117 | 396 |
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorRobert Plenge, M.D., Ph.D. | Sep 14, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Oruka Therapeutics, Inc.
Chief Commercial Officer appointed: Todd Edwards
- Executive appointment
director appointed: Robert Plenge, M.D., Ph.D.
Robert Plenge, M.D., Ph.D. was named director of BIOMARIN PHARMACEUTICAL INC, effective September 10, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 14, 2026Role: director
Last verified Nov 8, 2026